title: Metformin may maintain weight loss in obese patients with dysglycaemia initially treated with rimonabant.
authors.forename: A J
authors.initials: AJ
authors.lastname: Dawson
authors.forename: D D
authors.initials: DD
authors.lastname: Mellor
authors.forename: T
authors.initials: T
authors.lastname: Sathyapalan
authors.forename: E S
authors.initials: ES
authors.lastname: Kilpatrick
authors.forename: S L
authors.initials: SL
authors.lastname: Atkin
mesh_terms: D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008687:Metformin / Q000008:administration & dosage*; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D010880:Piperidines / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*; D000077285:Rimonabant; D015431:Weight Loss / Q000187:drug effects*
chemical_list: D007004:Hypoglycemic Agents; D010880:Piperidines; D011720:Pyrazoles; D008687:Metformin; D000077285:Rimonabant